Annual report [Section 13 and 15(d), not S-K Item 405]

Subsequent Events (Details)

v3.25.1
Subsequent Events (Details) - Subsequent Event - USD ($)
$ in Thousands
Jan. 29, 2025
Jan. 16, 2025
Discontinued Operations, Disposed of by Sale | Pharmaloz    
Subsequent Event [Line Items]    
Cash payment   $ 2,000
Extinguishment of debt   10,000
Capital expenditures avoided   3,000
Employee annual overhead   600
Discontinued Operations, Disposed of by Sale | Pharmaloz | PMI Note    
Subsequent Event [Line Items]    
Extinguishment of debt   3,300
Discontinued Operations, Disposed of by Sale | Pharmaloz | Capital Leases    
Subsequent Event [Line Items]    
Extinguishment of debt   2,000
Discontinued Operations, Disposed of by Sale | Pharmaloz | Current And Accrued Payables    
Subsequent Event [Line Items]    
Extinguishment of debt   3,000
Discontinued Operations, Disposed of by Sale | Pharmaloz | Existing Loan From Affiliates    
Subsequent Event [Line Items]    
Extinguishment of debt   200
Discontinued Operations, Disposed of by Sale | Pharmaloz | Accrued Interest    
Subsequent Event [Line Items]    
Extinguishment of debt   $ 300
Keystone    
Subsequent Event [Line Items]    
Number of shares of common stock sold (in shares) 7,730,973